MARKET

IMMVF

IMMVF

Immunovia Ab
EXMKT
3.000
NaN%
Closed 09:30 03/14 EDT
OPEN
--
PREV CLOSE
3.000
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
3.000
52 WEEK LOW
3.000
MARKET CAP
509.13M
P/E (TTM)
-35.8423
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at IMMVF last week (0310-0314)?
Weekly Report · 1h ago
Weekly Report: what happened at IMMVF last week (0303-0307)?
Weekly Report · 03/10 11:47
Weekly Report: what happened at IMMVF last week (0224-0228)?
Weekly Report · 03/03 11:46
Immunovia AB Reports Progress in Cancer Diagnostics
TipRanks · 02/26 03:56
Immunovia reports Q4 results
Seeking Alpha · 02/25 16:37
Weekly Report: what happened at IMMVF last week (0217-0221)?
Weekly Report · 02/24 11:46
Immunovia initiates search for a new CFO
Seeking Alpha · 02/21 18:00
Weekly Report: what happened at IMMVF last week (0210-0214)?
Weekly Report · 02/17 11:43
More
About IMMVF
Immunovia AB (publ) is a Sweden-based diagnostic company that is developing and commercializing blood tests for the early detection of cancer and autoimmune diseases based on Immunovia’s test platform called IMMray. Tests are based on antibody biomarker microarray analysis using machine-learning and bioinformatics to single-out a set of relevant biomarkers that indicate a certain disease. Thus, forming a disease biomarker signature. Immunovia Dx Laboratories locations in USA and Sweden provides laboratory testing services in two accredited reference laboratories.

Webull offers Immunovia AB (publ) stock information, including EXMKT: IMMVF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IMMVF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading IMMVF stock methods without spending real money on the virtual paper trading platform.